Bengaluru,
India: The number of cataract patients in India has been steadily
increasing, driven by the country’s aging population and the high prevalence of
risk factors such as diabetes, hypertension, and prolonged exposure to
ultraviolet (UV) radiation. According to recent studies, over 12 million
individuals in India are affected by cataracts, and this number is expected to
rise significantly in the coming years. The growing prevalence of cataracts is
not only a major public health concern but also poses a significant economic
burden due to the costs associated with treatment and loss of productivity.
This surge in cataract cases
underscores the urgent need for comprehensive eye care services and public
health interventions. Despite advancements in medical technology and surgical
techniques, access to quality cataract treatment remains uneven, particularly
in rural and underserved areas. Efforts to address this challenge include
increasing public awareness about cataracts, enhancing the availability of
diagnostic and surgical facilities, and training more ophthalmologists to meet
the rising demand for eye care services. Addressing these issues is critical to
preventing vision impairment and ensuring a better quality of life for millions
of individuals across India.
ZEISS Group in India is proud to
be at the forefront of revolutionizing cataract treatment with its innovative
ZEISS Premium Cataract Workflow during ongoing Cataract Awareness Month.
The ZEISS Premium Cataract
Workflow is an integrated solution designed to optimize every stage of the
cataract surgery process. From pre-operative diagnostics to post-operative
care, ZEISS provides a comprehensive suite of tools and technologies that
enhance the precision, safety, and efficiency of cataract surgeries.
Key Components of the ZEISS
Premium Cataract Workflow include:
Pre-operative Diagnostics: Accurate
diagnosis and planning are critical for successful cataract surgery. ZEISS
offers advanced diagnostic devices, such as the ZEISS IOLMaster® and the ZEISS
CIRRUS® HD-OCT, which provide detailed measurements and imaging of the eye.
These tools help ophthalmologists determine the appropriate intraocular lens
(IOL) and create a personalized treatment plan.
Surgical Planning and Guidance:
The ZEISS CALLISTO eye® and ZEISS FORUM® provide digital integration and
planning capabilities, allowing surgeons to visualize and plan the procedure
with high precision. The digital markers and overlays assist in accurate IOL
positioning and astigmatism management, ensuring optimal surgical outcomes.
Intraoperative Visualization
and Assistance: The ZEISS ARTEVO 800 and ZEISS OPMI LUMERA® surgical
microscopes deliver exceptional clarity and depth perception, enabling surgeons
to perform delicate procedures with confidence. Additionally, the ZEISS
CALLISTO eye® system provides real-time data and visual guidance during
surgery, enhancing precision and reducing the risk of complications.
Advanced Intraocular Lenses
(IOLs): ZEISS offers a range of premium IOLs, including the ZEISS AT LISA
tri, ZEISS AT LARA®, and ZEISS AT TORBI®, designed to meet the diverse needs of
patients. These lenses provide excellent visual outcomes, including improved near,
intermediate, and distance vision, and are available in Toric versions to
correct astigmatism.
Post-operative Care: ZEISS
FORUM® and the ZEISS EQ Mobile® app facilitate seamless post-operative
monitoring and data management. These tools allow ophthalmologists to track
patient progress, manage outcomes, and ensure that any issues are promptly
addressed.
ZEISS Group remains committed to
spreading awareness about the impact of cataracts and the importance of early
diagnosis and advanced treatment options. It is imperative for stakeholders,
including healthcare providers, policymakers, and communities, to collaborate
in addressing this growing health concern. By leveraging innovative solutions
like the ZEISS Premium Cataract Workflow and prioritizing comprehensive eye
care, we can significantly reduce the burden of cataracts, enhance the quality
of life for affected individuals, and ensure a brighter, clearer future for
millions across the nation.